Clinical Trial

Safety and Efficacy of Endoscopic Ultrasound (EUS) Guided Radiofrequency Ablation (RFA) in the Treatment of Pancreatic Lesions

Name: Safety and Efficacy of Endoscopic Ultrasound (EUS) Guided Radiofrequency Ablation (RFA) in the Treatment of Pancreatic Lesions — clinical trial record (NCT07737171)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting

View on ClinicalTrials.gov →

Summary

This is a 7-year prospective single-center registry study to assess the safety and efficacy of Endoscopic Ultrasound (EUS) Guided Radiofrequency Ablation (RFA) in the treatment of pancreatic lesions.

Trial Details

NCT Number	NCT07737171
Lead Sponsor	The University of Texas Health Science Center, Houston
Conditions	Pancreatic Cancer
Enrollment	60 participants
Start Date	2026-04-07
Primary Completion	2033-04-01 (estimated)
Study Completion	2033-04-01 (estimated)
Updated on ClinicalTrials.gov	2026-07-30